Transcription
n2021 SAPA Career Development WorkshopFor Students and Young ProfessionalsBreakinginto theIndustryVirtual SessionSaturdayMarch 27, 2021, 1pm – 7pmh t t p s : / / s a p a w e b . o r gRegistration is complimentaryclick HERE orscan QR code
Break into the IndustryExploring Career Opportunities in Biotech and Pharmaceutical IndustriesSAPA will host an interactive career development workshop exploring various careeropportunities in biotech and pharmaceutical industries.The participants will: Gain basic understanding of the biotech/pharmaceutical industry; Hear the stories from young professionals of how they broke into the industry; Talk to HR professionals, hiring managers, and immigration lawyers aboutnetworking and immigration challenges and issues.If you are a graduate student, a post-doctoral researcher, or someone who juststarted your career, this half-day workshop will open your eyes and help you explorethe industry that can offer vast career opportunities.MarchRegistration is complimentary and now open: click HERE27
Workshop Agenda1:00 – 1:10 pm SAPA CDW Opening Remark Yong GuoPresident’s Remark John Sun1:10 – 1:30 pm An Overview of Drug Development Process Yong Guo1:30 – 3:00 pm Panel Discussion on Biotech and Pharmaceutical IndustriesYvonne Cheng, Chenchao Gao, Andy Han, Xue Liang, Susie Wang,Xiaowen Wang, Yulan Zhang, and Jing Zhen3:00 – 3:10 pm Coffee Break3:10 – 4:30 pm Round Table Discussion on Networking and Interviews with HRProfessionals and Hiring ManagersXiaodong Chen, Alessandra Rober Christensen, Brian Freeman,Sara Gao, and Li Wan4:30 – 5:30 pm Round Table Discussion on Immigration IssuesBrian Freeman and Catherine Wadhwani5:30 – 7:00 pm Virtual Networking with Experienced Industry Professionals
Understanding the IndustryYong Guo, PhD, MBAProfessorSchool of Pharmacy andHealth SciencesFairleigh Dickinson UniversityIt is a long, complex and risky road to develop a new medicine. Understanding thiscomplex drug development process is the first step to find out what career opportunities thepharmaceutical and biotech industries can offer.We will briefly review the drug development process and identify the expertise required andopportunities presented for you.
Industry PanelDiscussion LeadsSiyu (Susie) Wang, PhDScientist,Proteomics/Chemical BiologyInzen TherapeuticsXiaowen Wang, PhDPostdoctoral Fellow,Merck & CoXue Liang, PhDSenior Scientist,MerckJing Zhen, PhDSenior Scientist,Viela BioAndy Han, M.Sc.Marketing/BusinessDevelopment Manager,Accurant Biotech, Inc.Yulan Zhang, MSAssociateHealth Economics &Outcome Research,KMK Consulting Inc.Chenchao Gao, PhDManager,Alliance Team andRegulatory StrategyDaiichi SankyoYao (Yvonne) ChengFull-time MBA, NYU Sternex-Senior Manager,Novartis
Networking & ImmigrationWorkshop InstructorsXiaodong Chen, PhDSenior Principal ScientistDrug Product DevelopmentTeam LeadBristol Myers SquibbSara Ying Gao, MScProgram DirectorWharton Executive EducationUniversity of PennsylvaniaAlessandra Rober Christensen, MSHead of University RelationsNovartisLi Wan, PhDVP, Head of Regulatory AffairsAlphamab OncologyBrian FreemanSenior ManagerTalent AcquisitionPTC TherapeuticsCatherine Wadhwani, JDPartner & Co-ChairImmigration Practice GroupFox Rothschild, LLP
Networking SessionsOther than the presentation and panel discussions, we have also organized severalnetworking breakout sessions, where the workshop participants will have additionalopportunities to discuss and get their questions answered according to their interests:A. Drug Discovery and Early ResearchB. Clinical Science and Development, Regulatory AffairsC. Medical Affairs, Commercialization, and Other FunctionsD. CMC (Process Development, Pharmaceutical Development, and AnalyticalDevelopment)
A. Drug Discovery& Early ResearchJian Liu, PhDCSO and Site Head,Eternity BioscienceYang Qiu, PhDSenior Director,Translational medicineDaiichi Sankyo, Inc.Xue Liang, PhDSenior Scientist,MerckSiyu (Susie) Wang, PhDScientist,Proteomics/Chemical BiologyInzen TherapeuticsDexi Yang, PhDSenior Scientist,Merck & Co
B. Clinical Science& Regulatory AffairsTuochuan Dong, PhDBiostatistician,NovartisChenchao Gao, PhDManager,Alliance Team andRegulatory StrategyDaiichi SankyoJerry J. Li, PhDPrincipal Scientist,BARDS, Global ClinicalDevelopment, MerckBrian (Yanming) Jiang, MSIT LeadRegeneronMike Hu, PhDChief Development Officer,Rafael PharmaceuticalsJohn Sun, PhD, MBAGlobal Program Lead,Novartis
C. Medical Affairs/CommercializationDavid Cragin, PhDDirector,Global ComplaintManagement, MerckYao (Yvonne) ChengFull-time MBA, NYU Sternex-Senior Manager,NovartisJerry Liu, PhD, JDPartner and Chair of ChinaPractice, Fox Rothschild LLPYulan Zhang, MSAssociateHealth Economics &Outcome Research,KMK Consulting Inc.Andy Han, M.Sc.Marketing/BusinessDevelopment Manager,Accurant Biotech, Inc.
D. CMCXiaodong Chen, PhDSenior Principal ScientistDrug Product DevelopmentTeam LeadBristol Myers SquibbXiaole Shen, PhDSenior Principal Scientist,Bristol Myers SquibbYiming Zhao, PhDStaff Scientist,RegeneronPharmaceuticsXiaowen Wang, PhDPostdoctoral Fellow,Merck & CoJing Zhen, PhDSenior Scientist,Viela Bio
Breakout RoomZoom linkSession1234SessionDescriptionEarly Drug Research(Discovery and PreclinicalDevelopment)Clinical Development(including RegulatoryAffairs and Biostatistics)Commercialization(including BusinessDevelopment)CMC (ProcessDevelopment,PharmaceuticalDevelopment andAnalytical Development)LeaderXue LiangSusie WangChenchao GaoYvonne ChengXiaowen WangMeeting ID816 6228 6686848 2102 4521867 7824 8463818 3786 0024PasswordLink 2286686?pwd 02web.zoom.us/j/84821024521?pwd 02web.zoom.us/j/86778248463?pwd 02web.zoom.us/j/81837860024?pwd OE52UjZYYlVpNW44d3NqdkxSQnFiUT09
Panelist BioAlways be curious,being interested inothers and the worldaround usXiaodong Chen, Ph.DBristol Myers SquibbSenior Principal ScientistDrug Product DevelopmentTeam LeadXiaodong is working as a drug product development team lead at BMS. He is leading matrixteams to recommend and implement development strategies for parenteral drug products andsupport regulatory submission throughout the development and commercialization. He coauthored three book chapters and a dozen publications. Xiaodong is actively involved inprofessional and community services: he is on the editorial advisory board of Journal ofPharmaceutical Sciences and invited reviewers for NIH contract proposals and scientificjournals. He has advised two NSF funded projects and served as session chairs in AiChe,AAPS, SMi Lyo Annual Conferences. He served as President of BMS Toastmaster club andArea Director of Toastmasters International at Area 43. In addition, he is leading PAN AsianNetwork Workplace at BMS. Xiaodong has also been a long-time volunteer and EC memberof SAPA since 2013, he is currently serving as President-elect of SAPA. Xiaodong receivedhis Ph.D. from the Ohio State University.
Panelist BioThe impossible journeyis the one you neverbeginAlessandra Rober Christensen, M.EdNovartisHead of University RelationsAlessandra is the Head of University Relations at Novartis. Prior to joining Novartis, she worked forover 7 years at the Massachusetts Institute of Technology. During her tenure at MIT, she was theSenior Associate Director for Employer Relations and Recruiting Services at the Sloan School ofManagement and Senior Assistant Director for Employer Relations at the MIT Global Education andCareer Development Office. In both roles, she provided team management, operational leadership,coaching and drove strategies to implement high-touch recruiting services for all students andalumni. Prior to MIT, she worked at Brandeis International Business School and as Assistant to theDean of the Graduate School at University of Miami. In addition, she served on the Board of ALPFABoston, a non-profit organization dedicated to developing Latino leaders.Alessandra is pursuing a Master in Innovation and Entrepreneurship at HEC Paris and has anExecutive Certificate in Management and Leadership from MIT Sloan School of Management, anM.Ed in Higher Education Administration and two Post-Masters certificates in EnrollmentManagement and Student Life and Development from University of Miami. She is also a graduate ofthe NACE Management Leadership Institute and Gallup’s Successful Strengths Coaching Certificateprogram.
Panelist BioEmbracing changesand moving forwardYvonne Cheng, CICPAYvonne is an MBA candidate and Advancing Women in Business Scholar at the SternSchool of Business at New York University.Full-time MBA, NYU Sternex-Senior Manager, NovartisPrior to joining Stern, Yvonne has over six years of working experience in thepharmaceutical industry in China and the US. She started her career as an auditor atKPMG Shanghai and later joined Roche Shanghai in the financial planning & analysisfunction. Yvonne then moved to the US and joined Novartis in the Market AccessBusiness Planning team, accomplishing a seamless career transition betweenChinese and American companies and cultures.In addition, Yvonne is actively involved in several non-profit organizations. She is anExecutive Council (EC) Member of SAPA and was also one of the ExecutiveCommittee members in the Chinese Culture Community at Novartis.
Panelist BioThrough quality youwill gain trustBrian FreemanBrian joined PTC Therapeutics in 2019 in the Talent Acquisition function supporting theCommercial, Clinical Development and Medical Affairs Departments.PTC TherapeuticsBrian earned his Bachelor of Science degree in Finance from Duquesne University and hasmore than fifteen years of experience in the Pharmaceuticals sector supporting multiplefunctional areas. Most recently, Brian comes to PTC Therapeutics from Stryker where heworked as a Talent Acquisition Lead. Prior to Stryker, he worked at Pfizer and Bausch andLomb. He has been integral in helping to grow talent acquisition teams aligning to the growth ofthe organization globally.Senior ManagerTalent AcquisitionBrian is a volunteer with the Cranford Jaycees, a local community outreach program and ishighly active in endurance racing.
Panelist BioPassionate andinnovativeChenchao Gao, PhDDaiichi SankyoManagerAlliance Team andRegulatory StrategyDr. Chenchao Gao is currently a manager in the Regulatory Strategy group at Daiichi Sankyo andhe also serves as the Alliance Team lead for a project with AstraZeneca.Prior to joining Daiichi Sankyo, Chenchao was a Clinical Regulatory Senior Specialist at Seagenand supported the company to successfully obtain FDA approvals for multiple Oncology drugs(Tukysa and Adcetris). Before that, he used to work at Genentech, where he helped theTECENTRIQ program to obtain FDA approvals for 4 new INDs. Before joining Genentech,Chenchao was an ORISE fellow at the FDA.Chenchao also served many key leadership positions in several non-profit organizations. He wasan Executive Council (EC) Member of SAPA since 2013 and co-chaired or organized events,including Career Development, Scientific Symposium, Clinical Development and RegulatoryAffairs Seminars. In addition, he was the president of Rutgers Chinese Student & ScholarAssociation (RCSSA) at Rutgers University. Chenchao obtained his Ph.D. degree in Cellular andMolecular Pharmacology from Rutgers University.
Panelist BioSuperconnectorInterdiscipilinarySocial ImpactSara Ying Gao, MScUniversity of PennsylvaniaProgram DirectorWharton Executive EducationBorn in China, educated in Europe, Sara Gao has worked in Europe, Asia and theUSA as a talent development expert in the past 16 years. Sara currently works asprogram director at Wharton Executive Education. Her passion is to bring seniorleaders from various industries around the world to a life changing learningexperience, so they are ready to create a positive impact for a better world. As acareer coach, Sara specializes in coaching Asian professionals to become successfulleaders in a multicultural environment.Sara started her career at Universum, a global employer branding consulting firm.She led her team to introduce the concept of Employer Branding to China for the firsttime. Sara worked with many global corporations to help them improve their talentattraction and retention strategies. Her clients include companies such as Johnson &Johnson, Novartis, Unilever, Procter & Gamble, Coca-Cola, and IBM. Sara graduatedfrom Stockholm School of Economics with a master degree of science majoring inbusiness.
Panelist BioLiving and Learning inboth worldsYong Guo, PhD, MBAFairleigh Dickinson UniversitySchool of Pharmacy and HealthSciencesProfessor of PharmaceuticalScienceChair, Department ofPharmaceutical ScienceYong is currently Professor of Pharmaceutical Science and Chair of Pharmaceutical SciencesDivision at the School of Pharmacy and Health Sciences, Fairleigh Dickinson University(FDU). Dr. Guo joined the FDU School of Pharmacy and Health Sciences in 2012 following a15-year career in pharmaceutical industry. At FDU, he teaches professional Doctor ofPharmacy (PharmD) students in the area of physical pharmacy, biopharmaceutics, andpharmaceutical biotechnology. Dr. Guo has published over 30 peer-reviewed journal articlesand 3 book chapters. His research focuses on separation mechanisms of chromatography andin-vitro drug release as well as quality assessment of herbal medicines. Prior to his academiccareer, Dr. Guo was an Associate Director at Janssen Pharmaceutical Research andDevelopment, a pharmaceutical company of Johnson & Johnson. He was responsible forleading and managing project teams in support of new drug development and registration, andhas made significant contributions to successful NDA and MAA filings.
Be AuthenticBe KindPanelist BioPhotoAndy Han, M.Sc.Accurant Biotech, Inc.Marketing/BusinessDevelopment ManagerAndy is currently a Business Development Manager at Accurant Biotech, Inc. His mainresponsibilities include exploring new leads and collaboration, maintaining businessrelationship and digital marketing using his R&D/engineering background and social mediamarketing skills. Prior to joining Accurant Biotech, Inc, Andy also worked as a TechnicalAccount Manager at Lifetein, LLC and a Research Associate at Columbia University.In SAPA, Andy is a long-time volunteer and an Executive Committee member since 2019. Heserves in the Registration and Membership Department and participates in the earlydevelopment and maintenance of the new SAPA Website. Andy received his Master ofScience in Chemical Engineering from Columbia University and a Bachelor of Science inChemical Engineering from Syracuse University in 2016.
Panelist BioExperienceEmbraceEmpowerXue Liang, PhDMerck & CoSenior ScientistXue is a Senior Scientist and Microbiome Project Lead at Merck & Co. and ispassionate about career planning and leadership development. In her daily job, sheleads and works in teams to uncover microbiome’s impact on xenobiotic metabolismand response to vaccine & cancer immunotherapies. Her work was published on topjournals such as Cell and PNAS, and she was invited to present at various domesticand international conferences. Xue has been an active volunteer and member ofExecutive Council of SAPA for 8 years, served as Lead of Volunteers, Lead ofInnovation, and Chair of 4 Career Development Workshops for biomedical students.Xue earned her Ph.D. in Pharmacology from University of Pennsylvania and B.S. inBiological Sciences from Chu Kochen Honors College at Zhejiang University. Xuewas awarded China’s National Scholarship in 2007, and the Inaugural Class of STATWunderkind in 2017.
Panelist BioIntrospect and inspireJohn Sun, PhD, MBA, PMPNovartisGlobal Program LeadJohn is a passionate practitioner and advocate for career planning and development.Currently he is a Global Program Lead at Novartis, and had served as GlobalAnalytics Project Manager and Global Program Team Director in different franchisesand units. Before Novartis, John held positions with increased R&D responsibilitiesfrom Whitehall-Robins, Kos Pharmaceuticals, Schering-Plough, and Sanofi-Aventis.Over the years, John has actively volunteered in various professional organizations,served as Chair of Project Management Community in DIA, SAPA President-Electand Career Lead, Chair of Chinese Culture Community, President of NovartisToastmasters Club and Area Director of Toastmasters International at District83. John had presented in various domestic and international symposia on PM anddrug development.John obtained his PhD in pharmaceutics from VirginiaCommonwealth University, MBA from Rutgers University, and BMed from BeijingUniversity of Traditional Chinese Medicine. John is a certified Project ManagementProfessional (PMP) and trained in black-belt for lean six-sigma.
Panelist BioMaking the most of eachconnectionCatherine WadhwaniFox Rothschild, LLPPartner & Co-ChairImmigration Practice GroupCatherine Wadhwani is co-chair of the Fox Rothschild Immigration practice group and a member ofthe firm's Labor & Employment Department. For more than 25 years, she has focused her practiceexclusively on immigration law, representing clients primarily in the health care, academia,business, technology and manufacturing industries. Catherine advises employers on issues relatedto work status, visa applications, immigration compliance and J-1 waiver applications. She alsocounsels individuals regarding their immigration options. Catherine is active in immigration issuesprofessionally and through volunteer organizations. She is a frequent writer and speaker onimmigration law issues, their evolution and impact on the business, academic and health carecommunities. She is the Chair of the Health Law Section of the Allegheny County Bar Association,a Member of the Bar’s Immigration Practitioner’s Committee, and a Member of the InternationalMedical Graduates Taskforce. Catherine is a past Chair of the Pittsburgh Chapter of the AmericanImmigration Lawyers Association.
Panelist BioStay foolishStay hungryLi Wan, Ph.DAlphamab OncologyVP, Head of Regulatory AffairsDr. Li Wan has over fifteen years of industry experience in the clinical development andregulatory affairs for innovative small molecule and biological oncology, CNS and ophthalmicproducts. He is currently the VP, Head of Regulatory Affairs at Alphamab Oncology and Headof Regulatory Affairs Department at SAPA.Before joining Alphamab Oncology, Dr. Wan was the VP, Head of Global Regulatory Affairs atLuye Pharma Group Ltd. Prior to Luye, he worked in the world-renowned big pharmaceuticalcompanies including Pfizer and Novartis. He has successfully led many global IND/CTA/NDAsubmissions and obtained approvals in the US, EU, and China, etc. He is a well-known expertin global regulatory affairs and has been an invited speaker at many professionalorganizations and conferences.Dr. Wan holds a doctoral degree in Pharmaceutical Science from Rutgers University and is acertified regulatory affairs professional by the Regulatory Affairs Professional Society, USA.
Panelist BioPassionate PivoterSiyu (Susie) Wang, Ph.D.Inzen Therapeutics – FlagshipPioneering CompanyScientistProteomics/Chemical BiologySusie is currently a proteomics/chemical biology scientist at Inzen therapeutics, early-stagebiotechnology company that was founded by Flagship pioneering and explores ThanokineTM Biologyas a surprising and important driver of disease. Susie serves as Proteomics lead in the foundingresearch team to develop a product platform to interrogate how living cells respond to the informationreleased from dying cells. Prior to join Inzen, Susie was a postdoc fellow at University ofPennsylvania, Perelman School of Medicine, leading research projects in proteomics and biomarkerresearch. Susie received both B.S. (sum cumma laude) and Ph.D. from Rutgers University in 2014and 2018, respectively.
Panelist BioBe your best selfXiaowen Wang, Ph.D.Merck & Co.Postdoctoral FellowBiologics Process DevelopmentXiaowen is currently an MRL (Merck Research Laboratories) Post-Doctorate Fellow in the BiologicsProcess Development group at Merck & Co. Dr. Wang received her Master's degree inPharmaceutical Analysis from Zhejiang University and her Ph.D. degree in Cellular and MolecularPharmacology from Rutgers University. Dr. Wang has a research background in cancer biology andcellular biology. Dr. Wang is a SAPA member and served as a SAPA volunteer since 2018. Dr. Wanghas been elected to SAPA Executive Council member in 2019-2021.
Curiosity DrivesPanelist BioPhotoJing Zhen, Ph.DViela BioSr. ScientistAnalytical ScienceStudied pharmaceutical chemistry between 2011 -2016 at Rutgers University. Aftergraduation joined Teva Pharmaceutical and worked in biologics characterization andanalytical method development group in support of manufacturing. Lead the massspectrometry lab and contributed to the regulatory filing of fremanezumab, which wasapproved in 2018. Currently working at Viela Bio, a spinout of AstraZeneca, insupport of analytical technical transfer and analytical activities management of CMO.Having 5 IND and 1 BLA filing experience.
Panelist BioForward-lookingexplorer in PharmaYulan Zhang, MSKMK Consulting Inc.AssociateHealth Economics & OutcomeResearchYulan is a healthcare consultant specialized in Health Economics & OutcomesResearch and experienced in real-world data analytics. Yulan advises clients onHEOR protocol design and data analysis to evaluate products’ real-world efficacy andsafety and to inform provider and payer strategies. Yulan led analysis for landscapeassessment and outcomes-based contracts to provide evidence and insights for thenegotiation of product tier and contract pricing. Currently, Yulan is conducting drugsafety evaluations related to real world adverse event reporting of newly launcheddrugs. Next she will explore strategies for launching drugs and oncology HEOR.Yulan holds a Master’s Degree in Biostatistics from Columbia University MailmanSchool of Public Health and a Bachelor’s Degree in Biochemistry & Cell Biology andManagement Science from University of California San Diego.
Organizing CommitteeWorkshop LeadYong GuoOrganizing CommitteeShuhui ChenXiaodong ChenYvonne ChengChenchao GaoAndy HanYanming (Brian) JiangYining JiangJohn SunXiaowen WangYulan ZhangYiming Zhao
About SAPAThe Sino-American Pharmaceutical Professionals Association (SAPA) was establishedin 1993 and is headquartered in the center of the pharmaceutical corridor in NewJersey, USA. Since its inception, SAPA rapidly became one of the most active Chineseprofessional associations in the US with eight chapters and more than 6,000 members.SAPA’s members are primarily from large and mid-sized pharmaceutical and biotechcompanies in the US, with areas of expertise covering almost every aspect ofpharmaceutical research and development as well as production.The organization’s large membership base and their superb scientific and technicalabilities has allowed SAPA to be a key source for knowledge exchange on the latestdevelopments in the pharmaceutical, biotechnology, and generic drug industries.As a non-profit organization registered in the US, SAPA receives generous sponsorshipand support from numerous multinational companies in the US and overseas. SAPAwill continue to provide a broad platform for scientific and technical discussion, talentexchange, and training for the colleagues in the pharmaceutical industry from the USand China.
nSAPA MissionAs a global organization, SAPA’s mission is: To promote the advancement of pharmaceutical science and biotechnology To contribute to public health education To promote entrepreneurship, healthcare investment and business cooperation To foster the career growth of pharmaceutical professionalsFollow SAPA witter:@SAPA 001WeChat:SAPAFacebook:SapaSapah t t p s : / / s a p a w e b . o r g
nIf you are interested in Getting additional information on SAPA career development workshop or having morequestions after the event; Joining SAPA Job Search Wechat group; Connecting with other SAPA members; Becoming a SAPA volunteerPlease feel free to scan QR code tojoin 2021 CDW Wechat Group
Program Director Wharton Executive Education University of Pennsylvania Li Wan, PhD VP, Head of Regulatory Affairs . Area Director of Toastmasters International at Area 43. In addition, he is leading PAN Asian Network Workplace at BMS. Xiaodong has also been a long-time volunteer and EC member of SAPA since 2013, he is currently serving as .
